​

Syndax Pharmaceuticals (SNDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Syndax Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$23.68M

Latest Revenue (Q)

$37.96M

Main Segment (Y)

Milestone Revenue

Syndax Pharmaceuticals Revenue by Period

Syndax Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$23.68M100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$139.71M9109.56%
2020-12-31$1.52M-
2019-12-31$1.52M-
2018-12-31$1.52M-28.04%
2017-12-31$2.11M72.79%
2016-12-31$1.22M94.58%
2015-12-31$627.00K100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Syndax Pharmaceuticals generated $23.68M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 1560.98% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30$37.96M89.39%
2025-03-31$20.04M160.96%
2024-12-31$7.68M-38.56%
2024-09-30$12.50M257.14%
2024-06-30$3.50M100.00%
2024-03-31--100.00%
2023-12-31$536.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$126.58M922.84%
2021-09-30$12.38M3165.17%
2021-06-30$379.00K-
2021-03-31$379.00K-0.26%
2020-12-31$380.00K0.26%
2020-09-30$379.00K-
2020-06-30$379.00K-
2020-03-31$379.00K-0.26%
2019-12-31$380.00K0.26%
2019-09-30$379.00K-
2019-06-30$379.00K-
2019-03-31$379.00K-0.26%
2018-12-31$380.00K0.26%
2018-09-30$379.00K-
2018-06-30$379.00K-
2018-03-31$379.00K-68.23%
2017-12-31$1.19M291.15%
2017-09-30$305.00K-
2017-06-30$305.00K-
2017-03-31$305.00K-
2016-12-31$305.00K-
2016-09-30$305.00K-
2016-06-30$305.00K-
2016-03-31$305.00K-
2015-12-31$305.00K-
2015-09-30$305.00K1694.12%
2015-06-30$17.00K100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Syndax Pharmaceuticals generated $37.96M in revenue during Q2 2025, up 89.39% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue Breakdown

Syndax Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Milestone Revenue$16.00M
Net Product Revenues$7.68M

Syndax Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestone Revenue (67.57%), and Net Product Revenues (32.43%).

Quarterly Revenue by Product

Product/ServiceJun 25
Collaboration revenue$9.36M
Product$28.60M

Syndax Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (75.35%), and Collaboration revenue (24.65%).

Syndax Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WVEWave Life Sciences$108.30M$8.70M
AMLXAmylyx Pharmaceuticals$87.37M-
IMTXImmatics$54.00M$30.45M
SNDXSyndax Pharmaceuticals$23.68M$37.96M
IMNMImmunome$9.04M$2.93M
PRAXPraxis Precision Medicines$8.55M-
ATAIAtai Life Sciences-$1.55M
ELVNEnliven Therapeutics--
SYRESpyre Therapeutics--
SANASana Bio--
ORICORIC Pharmaceuticals--

SNDX Revenue FAQ

What is Syndax Pharmaceuticals’s yearly revenue?

Syndax Pharmaceuticals's yearly revenue for 2024 was $23.68M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. SNDX's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Syndax Pharmaceuticals’s quarterly revenue?

Syndax Pharmaceuticals's quarterly revenue for Q2 2025 was $37.96M, a 89.39% increase from the previous quarter (Q1 2025), and a 984.51% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $20.04M, a 160.96% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). SNDX's quarterly revenue for Q4 2024 was $7.68M, a -38.56% decrease from the previous quarter (Q3 2024), and a 1332.84% increase year-over-year (Q4 2023).

What is Syndax Pharmaceuticals’s revenue growth rate?

Syndax Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 1460.98%.

What are Syndax Pharmaceuticals’s revenue streams?

Syndax Pharmaceuticals's revenue streams in c 24 are Milestone Revenue, and Net Product Revenues. Milestone Revenue generated $16M in revenue, accounting 67.57% of the company's total revenue Net Product Revenues generated $7.68M in revenue, accounting 32.43% of the company's total revenue

What is Syndax Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Syndax Pharmaceuticals was Milestone Revenue. This segment made a revenue of $16M, representing 67.57% of the company's total revenue.